Home > Stock Certs >

Diagnostek, Inc. Production Proof - Rare
Diagnostek, Inc. Stock Certificate Production Proof
Diagnostek, Inc. Stock Certificate Production Proof


 
Alternative Views:


Stock Cert Sale: Spend $200 save 10%, $350 save 20%, $500 save 25% - Mix or Match
Our Price: $240.00
Sale Price: $198.00
Vintage Stock Certificate



Product Code: OD116
Qty:

Description Extended Information
 
This rare Diagnostek Stock Certificate production proof from the American Banknote Company includes the general stock certificate layout with various pieces glued on for the placement of the legal language, vignette and details with hand-written notes as well as the transparency that can be lifted showing various notes. The top also has two alternative vignette with is really rare. Fantastic display.

This Diagnostek production piece is rare and a true one-of-one. These proofs rarely make it into the public.

Dated 1990 - Marked ok to engrave; American Bank Note Company

Diagnostek Inc. is a health care company that provides prescription drugs via mail and leases equipment to hospitals. In 1995 it was bought out and became a wholly owned subsidiary of Value Health Inc.

Stock Certificate Production Proofs / Mock-ups are the design and legal blue print for the stock certificate issue. Proofs were used by the banknote company that printed the stock certificates and executives at the company for review and editing. These proofs helped to design the layout and art on the stock certificate and to assure that all the legal language and design elements were included. Many of these are several pages with clear plastic transparency sheets to allow for notes and directions on subsequent layers. Proofs sometimes have the vignettes and photos taped in place and may even have the original photos included separately. Stock Certificate Mock-ups were always a work in progress so they were handled often and show the wear and tear of the process. These are always truly one-of-ones making each exceedingly rare and don't often make it to the public.